PR Newswire·Mar 25, 2026, 5:15 AM ET

So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

So-Young International Inc. reported Q4 2025 total revenues of RMB460.7 million (US$65.9 million), a 24.8% increase year-over-year, driven by aesthetic treatment services.
Aesthetic treatment services revenues in Q4 2025 reached RMB248.1 million (US$35.5 million), up 205.3% from the prior year, exceeding guidance highs.
Net loss attributable to So-Young for Q4 2025 was RMB108.8 million (US$15.6 million), significantly lower than the RMB607.6 million loss recorded in the same period of 2024.
Non-GAAP net loss for Q4 2025 was RMB93.4 million (US$13.2 million), compared to RMB53.2 million in Q4 2024.
Operational growth in Q4 2025 included over 125,000 verified treatment visits to branded centers and more than 289,400 verified aesthetic treatments performed.
Active users in Q4 2025 exceeded 171,000, up from approximately 52,700 in the corresponding 2024 period.
Core members grew by over 14,500 in the quarter (a 39% sequential increase), with both revenue contribution \& repurchase rates exceeding 80%.
As of December 31, 2025, So-Young operated 49 branded aesthetic centers across 15 major cities, with 25 centers achieving profitability \& 39 generating positive quarterly operating cash flow.
Fiscal year 2025 total revenues were RMB1,523.4 million (US$217.8 million), up 3.9% from the prior year, with aesthetic treatment services revenues surging 298.7% to RMB674.9 million.
Fiscal year 2025 net loss was RMB242.3 million (US$34.6 million), a substantial improvement from the RMB589.5 million loss in 2024.
The company extended its share repurchase program by 12 months to March 31, 2027, having repurchased approximately 4.8 million ADSs in 2024 \& 2025.
For Q1 2026, So-Young forecasts aesthetic treatment services revenues between RMB268.0 million \& RMB278.0 million, representing a 171.2% to 181.3% increase year-over-year.
Cash, restricted cash, term deposits, \& short-term investments totaled RMB936.4 million as of December 31, 2025, down from RMB1,253.2 million in 2024 due to increased investment in aesthetic centers.